Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.434
-0.010 (-2.32%)
Apr 29, 2026, 1:55 PM EDT - Market open
Silo Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 4.75 | 3.91 | 3.52 | 11.37 | 9.84 | Upgrade
|
| Short-Term Investments | 2.11 | 3.17 | 4.14 | 0 | 0.42 | Upgrade
|
| Cash & Short-Term Investments | 6.86 | 7.08 | 7.67 | 11.37 | 10.26 | Upgrade
|
| Cash Growth | -3.13% | -7.63% | -32.58% | 10.85% | 808.83% | Upgrade
|
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Receivables | 0 | 0 | 0 | 0.07 | 0 | Upgrade
|
| Prepaid Expenses | 0.19 | 0.03 | 0.01 | 0.12 | 0.06 | Upgrade
|
| Other Current Assets | 0.34 | 0.01 | 0.01 | 0.02 | 0.08 | Upgrade
|
| Total Current Assets | 7.39 | 7.11 | 7.68 | 11.57 | 10.4 | Upgrade
|
| Other Intangible Assets | 0.22 | 0.24 | - | - | - | Upgrade
|
| Long-Term Accounts Receivable | - | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Long-Term Deferred Charges | - | 0.05 | 0.06 | 0.06 | 0.02 | Upgrade
|
| Total Assets | 7.61 | 7.41 | 7.75 | 11.64 | 10.49 | Upgrade
|
| Accounts Payable | 0.58 | 1.58 | 0.7 | 0.22 | 0.42 | Upgrade
|
| Accrued Expenses | - | - | - | 0.14 | - | Upgrade
|
| Current Unearned Revenue | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Total Current Liabilities | 0.65 | 1.66 | 0.78 | 0.44 | 0.49 | Upgrade
|
| Long-Term Unearned Revenue | 0.65 | 0.72 | 0.79 | 0.87 | 0.94 | Upgrade
|
| Total Liabilities | 1.3 | 2.38 | 1.57 | 1.3 | 1.43 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 25.79 | 20.3 | 17.53 | 17.51 | 12.32 | Upgrade
|
| Retained Earnings | -19.49 | -15.26 | -10.87 | -7.17 | -3.26 | Upgrade
|
| Treasury Stock | - | - | -0.47 | - | - | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0 | -0.01 | - | - | Upgrade
|
| Total Common Equity | 6.31 | 5.03 | 6.18 | 10.34 | 9.06 | Upgrade
|
| Shareholders' Equity | 6.31 | 5.03 | 6.18 | 10.34 | 9.06 | Upgrade
|
| Total Liabilities & Equity | 7.61 | 7.41 | 7.75 | 11.64 | 10.49 | Upgrade
|
| Net Cash (Debt) | 6.86 | 7.08 | 7.67 | 11.37 | 10.26 | Upgrade
|
| Net Cash Growth | -3.13% | -7.63% | -32.58% | 10.85% | 824.31% | Upgrade
|
| Net Cash Per Share | 0.82 | 1.92 | 2.49 | 4.98 | 5.35 | Upgrade
|
| Filing Date Shares Outstanding | 14.17 | 4.48 | 2.84 | 3.16 | 1.97 | Upgrade
|
| Total Common Shares Outstanding | 13.32 | 4.48 | 2.91 | 3.16 | 1.97 | Upgrade
|
| Working Capital | 6.74 | 5.46 | 6.91 | 11.14 | 9.91 | Upgrade
|
| Book Value Per Share | 0.47 | 1.12 | 2.13 | 3.27 | 4.59 | Upgrade
|
| Tangible Book Value | 6.09 | 4.79 | 6.18 | 10.34 | 9.06 | Upgrade
|
| Tangible Book Value Per Share | 0.46 | 1.07 | 2.13 | 3.27 | 4.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.